Tech Company Financing Transactions
Armo Bio Sciences Funding Round
On 11/26/2013, Armo Bio Sciences secured $20 million in Series A funding from DAG Ventures, Kleiner Perkins Caufield & Byers and OrbiMed.
Transaction Overview
Company Name
Announced On
11/26/2013
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
575 Chesapeake Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Undisclosed
Website
Email Address
Overview
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Van Vlasselaer
Chief Medical Officer
Joseph Leveque
Founder
Martin Oft
VP - Bus. Development
Scott Ogg
VP - Operations
Russell Kawahata
Browse more venture capital transactions:
Prev: 11/26/2013: ABSMaterials venture capital transaction
Next: 11/27/2013: Branding Brand venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs